To Compare Uroflowmetric Parameters in Benign Prostatic Hyperplasia Pre and Post Trans Urethral Resection of Prostate
Abstract
Introduction: Men’s lower urinary tract problems sometimes stem from benign prostatic hyperplasia (BPH), the noncancerous growth of prostate tissue. Disease rates rise with age. The histological prevalence of BPH at autopsy is 50 to 60% in men in their 60s and 80 to 90% in those over 70.
Material and Methods: The Shri Ram Murti Smarak Institute of Medical Sciences’ General Surgery Department conducted the prospective study with Ethics Committee approval. All lower urinary tract patients aged 40 to 80 who needed surgery (transurethral resection of the prostate). The 18-month research assessed 50 patients.
Results: IPSS patients were moderate in the post-treatment, 1, and 3 months period, however only 6% were moderate and 94% were severe in the pre-treatment period. In QMAX, all patients were under 10 before treatment, 36% were between 10 and 15 after treatment, 64% were above 15 one month after treatment, and 14% were between 10 and 15, 3 months later. QMAX scores averaged 6.62 ± 1.03, 15.9 ± 1.84, 16.64 ± 1.22, and 17 ± 1.24. In QAVG, all patients were under 10 before treatment, 74% were under 10, 26% were between 10 and 15, 58% were under 10, 42% were between 10 and 15, and 36% were under 10 and 64% were over 15 during the 3 month treatment. Q avg score mean was 3.22 ± 0.78, 8.74 ± 1.29, 9.3 ± 1.15, and 10.22 ± 1.06. In the post-treatment, 1 and 3 month follow-up periods, all Tmax patients were under 10, whereas in the pre-treatment period, 76% were between 10 to 15 and 24% were beyond 15. Tmax averaged 14.66 ± 1.47, 6.9 ± 0.64, 6.34 ± 0.62, and 5.68 ± 0.61.
Conclusion: After TURP, objective uroflowmetry measures improved and correlated with subjective IPSS scores. Thus, uroflowmetry can objectively assess bladder outlet obstruction symptoms after TURP.